Document:

EX-10.3

 Exhibit 10.3 
 EXECUTION VERSION 
 AMENDED AND RESTATED STOCK OPTION GRANT AGREEMENT

 (Non-Qualified Stock Options) 
 THIS AMENDED AND RESTATED AGREEMENT is made as of this 14th day of January, 2013 by and between LVB Acquisition, Inc. (the “Company”) and Jeffrey R. Binder (the
“Participant”). 
 WHEREAS, the Company has adopted and maintains the LVB Acquisition, Inc. Management Equity
Incentive Plan, as amended, (the “Plan”) to promote the interests of the Company and its Affiliates and stockholders by providing the Company’s key employees and others with an appropriate incentive to encourage them to
continue in the employ of and provide services for the Company or its Affiliates and to improve the growth and profitability of the Company; 
 WHEREAS, the Plan provides for the Grant to Participants in the Plan of Non-Qualified Stock Options to purchase shares of Common Stock of the Company; 

WHEREAS, the Company and the Participant entered into that certain Stock Option Grant Agreement dated as of July 31, 2012, as
amended (the “Prior Agreement”); 
 WHEREAS, Section 4.12 of the Plan provides that the Board of Directors
of the Company may, in its discretion, amend the Plan or the terms of any Stock Option; 
 WHEREAS, the Company and the
Participant desire to amend and restate the Prior Agreement to provide certain benefits upon termination of employment; 
 NOW,
THEREFORE, in consideration of the premises and the mutual covenants hereinafter set forth, the parties hereto hereby agree as follows: 
 1. Grant of Options. Pursuant to, and subject to, the terms and conditions set forth herein and in the Plan, the Company hereby grants to the Participant a NON-QUALIFIED STOCK OPTION (the
“Option”) with respect to 4,200,000 shares of Common Stock of the Company. Fifty percent (50%) of the Option (representing an Option to purchase 2,100,000 shares) will be a time based Option (the “Revised Time Vesting
Option”), twenty-five percent (25%) of the Option (representing an Option to purchase 1,050,000 shares) will be a time based Option with a longer vesting period than that which applies to the Revised Time Vesting Option (the
“Replacement Extended Time Vesting Option”) and twenty-five percent (25%) of the Option (representing an Option to purchase 1,050,000 shares) will be a performance based Option having the terms set forth in this agreement (the
“Modified Performance Option”). For purposes of the Option, (i) references in the Plan to “Options” will be deemed to include “Revised Time Vesting Options,” “Replacement Extended Time Vesting
Options” and “Modified Performance Options” unless specifically noted to the contrary and (ii) the references in Section 2(y) and Section 2(dd) of the Plan to “Performance Based Options” shall be construed to
refer to “Modified Performance Options” as defined herein. 
 2. Grant Date. The Grant Date of the Option
hereby granted is July 31, 2012. 

 3. Incorporation of Plan. Unless stated otherwise, all terms, conditions and
restrictions of the Plan are incorporated herein and made part hereof as if stated herein. All capitalized terms used and not defined herein shall have the meaning given to such terms in the Plan. 

4. Exercise Price. The exercise price per share of Common Stock underlying the Option hereby granted is $7.88. 

5. Vesting Date. The Option shall become exercisable as follows: 

a. Revised Time Vesting Option. With respect to the portion of the Option that is a Revised Time Vesting Option:

  

	 	i.	One Hundred percent (100%) shall be vested as of the Grant Date. 

b. Replacement Extended Time Vesting Option. With respect to the portion of the Option that is an Replacement
Extended Time Vesting Option: 
  

	 	i.	Eighty-Five percent (85%) shall be vested as of the Grant Date; and 

  

	 	ii.	Five percent (5%) shall vest on July 11 in each of calendar years 2013, 2014 and 2015. 

c. Modified Performance Option. With respect to the portion of the Option that is a Modified Performance Option:

  

	 	i.	Fifty-five percent (55%) shall be vested as of the Grant Date; and 

  

	 	ii.	Fifteen percent (15%) shall vest on July 11 in each of calendar years 2013, 2014 and 2015 if, as of the end of the Company’s most recent fiscal year
ending on or prior to such Vesting Date, Biomet, Inc. has achieved the EBITDA target for such fiscal year determined by the Committee, consistent with the annual business plan for such fiscal year, on or before the ninetieth (90th) day of such
fiscal year, subject in each case to the Participant’s continued Employment through each such Vesting Date. 

If any portion of the Modified Performance Option does not vest on the Vesting Date on which it initially becomes eligible to vest in
accordance with the vesting provisions set forth above in this sub-section (c) because Biomet, Inc. did not meet the EBITDA target set by the Committee for the relevant fiscal year (any such year, the “Below-Target Year”), then
such portion (the “Catch-Up Tranche”) shall remain outstanding and shall be eligible to vest as follows: 
 (A) If Biomet, Inc. exceeds the EBITDA target set by the Committee for the fiscal year immediately following such Below-Target Year (the “Catch-Up Year”) by an amount large enough so that
(I) the sum of Biomet, Inc.’s actual 

  
 2 

 
EBITDA in the Below-Target Year and its actual EBITDA in the Catch-Up Year exceeds (II) the sum of the EBITDA target set by the Committee for the Below-Target Year and the EBITDA target set by
the Committee for the Catch-Up Year, then such Catch-Up Tranche will vest as of the Vesting Date that occurs on or next following the last day of the Catch-Up Year. 

(B) If either: 
 (I) After the end of the Below-Target Year, a Liquidity Event occurs in which the Majority Stockholder realizes an MoM that is at least 1.25; or 

(II) (a) An Initial Public Offering has occurred, (b) the Majority Stockholder has sold, directly or
indirectly, in one or more Liquidity Event(s), 80% or more of the Initial Majority Stockholder Shares (determined based on the number of the Initial Majority Stockholder Shares as of the Closing date) and (c) the Majority Stockholder has
realized, directly or indirectly, in such Liquidity Event(s) an MoM that is at least 1.25 (provided that MoM for this purpose shall be determined by multiplying clause (ii) of Section 2(dd) of the Plan by a fraction, the numerator
of which is the number of Initial Majority Stockholder Shares disposed of in all such Liquidity Events and the denominator of which is the number of the Initial Majority Stockholder Shares as of the Closing date); provided further that to the
extent any such Liquidity Event does not result in the sale, transfer or other disposition of Initial Majority Stockholder Shares, such fraction shall be equitably adjusted by the Board as appropriate to reflect the conversion of equity value into
cash in connection with such Liquidity Event; 
 then any Catch-Up Tranche that remains unvested as of the occurrence of the
Liquidity Event shall immediately vest upon the occurrence of the Liquidity Event, provided the Participant remains Employed through such Vesting Date. 
 d. Accelerated Vesting. 
  

	 	i.	Solely for purposes of the Option, (i) the reference in Section 4.4(b) of the Plan to “Time Based Options” shall be construed to refer to
“Revised Time Vesting Options” as defined herein, (ii) the reference in Section 4.4(b) of the Plan to “Hurdle Options” shall be construed to refer to “Replacement Extended Time Vesting Options” as defined
herein and (iii) the reference in Section 4.4(c) of the Plan to “Performance Based Options” shall be construed to refer to “Modified Performance Options” as defined herein. 

 

	 	ii.	 If the Company terminates the Participant’s Employment other than for Cause, death, or Disability or the Participant terminates Employment for
Good Reason, prior to January 1, 2015, (i) any 

  
 3 

	 	
unvested Replacement Extended Time Vesting Options then held by the Participant that would have vested under Section 5(b) of this Agreement had Participant remained Employed through
January 1, 2015 shall vest immediately as of the date of the Participant’s termination of Employment and (ii) the remaining unvested Replacement Extended Time Vesting Options shall expire on the date the Participant’s Employment
is terminated pursuant to Section 6 hereof. 

  

	 	iii.	Notwithstanding anything in the Plan to the contrary, for purposes of this Section 5(d), “Good Reason” shall be defined as in the Amended and Restated
Employment Agreement, by and between Biomet, Inc. and the Participant, dated as of January 14, 2013; provided that any termination of employment by the Participant prior to January 1, 2014 may not be treated as a termination for Good
Reason under clause (iv) of the definition thereof. 

 6. Expiration Date. 

a. Subject to the provisions of the Plan, with respect to the Option or any portion thereof which has not become
exercisable, the Option shall expire on the date the Participant’s Employment is terminated for any reason, and with respect to any Option or any portion thereof which has become exercisable, the Option shall expire on the earliest to occur of
(i) the commencement of business on the date the Participant’s Employment is terminated for Cause; (ii) subject to Section 6(b), 30 days following the date the Participant resigns from Employment without Good Reason,
(iii) subject to Section 6(c), 90 days after the date the Participant’s Employment is terminated by the Company for any reason other than: for Cause, by reason of death or Disability or due to the Participant’s
resignation from Employment with Good Reason; (iv) one year after the date the Participant’s Employment is terminated by reason of death or Disability; or (v) the tenth anniversary of the original Grant Date. For the avoidance of
doubt, the Option, or portion thereof, that has become exercisable by a Permitted Transferee on account of the death of a Participant shall expire one year after the date such deceased Participant’s Employment terminated by reason of death, and
the Option or portion thereof that has been transferred to a Permitted Transferee during the lifetime of a Participant shall expire in connection with the Participant’s termination of Employment at the time set forth under this
Section 6(a) as if the Option were held directly by the Participant. Notwithstanding the foregoing, in the event that (A) the Participant is employed on the Vesting Date applicable to any portion of his or her Modified Performance Based
Option, (B) the Participant’s Employment is terminated prior to the time at which the Board determines whether the EBITDA target applicable to such portion of Participant’s Modified Performance Based Option (and/or the EBITDA target
for any Catch-Up Year) was met and (C) the Board subsequently determines that such EBITDA target was met, then the time period set forth in clause (ii), (iii) or (iv) of the first sentence of this Section 6(a) (as applicable)
shall begin to run with respect to such portion or portions of Participant’s Modified Performance Based Option as of the date on which the Participant is notified that the Board determined that the relevant EBITDA target was met rather than

  
 4 

 
as of the date of termination of Participant’s Employment. In no event shall the Option remain outstanding after the date set forth in clause (v) of the first sentence of this
Section 6(a). 
 b. If the Participant terminates Employment without Good Reason and his employment could
not be terminated by the Company for Cause at such time, then: 
  

	 	i.	In the event that the Participant remains continuously Employed with the Company through January 1, 2014, seventy percent (70%) of the portion of the
Participant’s Option vested as of the date Participant terminates Employment shall remain outstanding until the tenth anniversary of the original Grant Date. 

 

	 	ii.	In the event that the Participant remains continuously Employed with the Company through July 1, 2014, eighty-five percent (85%) of the portion of the
Participant’s Option vested as of the date Participant terminates Employment shall remain outstanding until the tenth anniversary of the original Grant Date. 

 

	 	iii.	In the event that the Participant has remained continuously Employed by the Company through January 1, 2015, one hundred percent (100%) of the portion of the
Participant’s Option vested as of the date Participant terminates Employment shall remain outstanding until the tenth anniversary of the original Grant Date. 

c. If the Company terminates the Participant’s Employment other than for Cause, death, or Disability or the
Participant terminates Employment for Good Reason, one hundred percent (100%) of the portion of the Participant’s Option vested as of the date Participant terminates Employment shall remain outstanding until the tenth anniversary of the
original Grant Date. 
 7. Construction of Agreement. Any provision of this Agreement (or portion thereof) which is
deemed invalid, illegal or unenforceable in any jurisdiction shall, as to that jurisdiction and subject to this section, be ineffective to the extent of such invalidity, illegality or unenforceability, without affecting in any way the remaining
provisions thereof in such jurisdiction or rendering that or any other provisions of this Agreement invalid, illegal, or unenforceable in any other jurisdiction. If any covenant should be deemed invalid, illegal or unenforceable because its scope is
considered excessive, such covenant shall be modified so that the scope of the covenant is reduced only to the minimum extent necessary to render the modified covenant valid, legal and enforceable. No waiver of any provision or violation of this
Agreement by the Company shall be implied by the Company’s forbearance or failure to take action. No provision of this Agreement shall be given effect to the extent that such provision would cause any tax to become due under Section 409A
of the Code; provided that the Company shall use commercially reasonable efforts to put the Participants in the same position in which they would have been but for the application of this Section 7. 

  
 5 

 8. Delays or Omissions. No delay or omission to exercise any right, power or remedy
accruing to any party hereto upon any breach or default of any party under this Agreement, shall impair any such right, power or remedy of such party nor shall it be construed to be a waiver of any such breach or default, or an acquiescence therein,
or of or in any similar breach or default thereafter occurring nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent or approval of any
kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party or any provisions or conditions of this Agreement, shall be in writing and shall be effective only to the extent
specifically set forth in such writing. 
 9. Limitation on Transfer. The Option shall be exercisable only by the
Participant or the Participant’s Permitted Transferee(s), as determined in accordance with the terms of the Plan (including without limitation the requirement that the Participant obtain the prior written approval by the Board of any proposed
Transfer to a Permitted Transferee during the lifetime of the Participant). Each Permitted Transferee shall be subject to all the restrictions, obligations, and responsibilities that apply to the Participant under the Plan and this Stock Option
Grant Agreement and shall be entitled to all the rights of the Participant under the Plan, provided that in respect of any Permitted Transferee which is a trust or custodianship, the Option shall become exercisable and/or expire based on the
Employment and termination of Employment of the Participant. All shares of Common Stock obtained pursuant to the Option granted herein shall not be transferred except as provided in the Management Stockholders’ Agreement. 

10. Restrictive Covenants. 
 a. Confidentiality and Trade Secrets. By accepting an award under the Plan, Participant agrees to hold in strict confidence any proprietary or Confidential Information related to the Company and
its Affiliates. For purposes of this Agreement, the term “Confidential Information” shall mean all information of the Company or any of its Affiliates (in whatever form) which is not generally known to the public, including without
limitation any inventions, processes, methods of distribution, customer lists, customers’ secrets or Trade Secrets. For purposes of this Agreement, “Trade Secrets” shall mean all Confidential Information, including, without
limitation, formulae, patterns, compilations, programs, devices, methods, techniques, or processes, from which the Company or any of its Affiliates derives independent economic value, actual or potential, because such information is not generally
known to, or readily ascertainable by proper means by, other persons who can obtain economic value from its disclosure or use and which the Company and its Affiliates make reasonable efforts to maintain secret. 

b. Non-Competition. Participant agrees that the Company would likely suffer significant and irreparable harm from
Participant’s competing with the Company or any of its Subsidiaries during the Participant’s Employment and for some period of time thereafter. Accordingly, by accepting an award under the Plan, Participant agrees that he or she will not,
during Participant’s Employment and for a period of twelve (12) months following termination of his or her Employment, directly or indirectly perform Competitive Services (as defined below) for any person, firm, partnership, corporation,
or other entity which develops, manufactures, markets, distributes, or sells products 

  
 6 

 
materially similar to or competitive with those products developed, manufactured, marketed, distributed, or sold by the Company or any of its Subsidiaries or included in the business plans of the
Company or any of its Subsidiaries during the term of Participant’s Employment (any such person, firm, partnership, corporation, or other entity, a “Competitor”). For purposes of this Agreement, “Competitive
Services” means services provided to a Competitor: (A) which are substantially similar to those provided by Participant to the Company or any of its Subsidiaries during his or her employment with the Company or any of its Subsidiaries;
(B) where Participant’s direct or indirect use or disclosure of the Company’s or any of its Affiliates’ Confidential Information or Trade Secrets to or on behalf of the Competitor would provide the Competitor with a competitive
advantage; (C) where it is likely that as part of Participant’s capacity he or she would inevitably use or disclose any of the Company’s or any of its Affiliates’ Confidential Information or Trade Secrets; (D) where
Participant solicits, attempts to solicit, or engages in discussions or other communications with any past, present or potential customer of the Company or any of its Subsidiaries with whom Participant communicated or had any interaction during the
preceding eighteen (18) months with the purpose or intent of promoting, marketing, selling, or obtaining orders for any Competing Product; or (E) where Participant interferes adversely with any past, present, or prospective business
relationships between the Company or any of its Subsidiaries and any of their respective customers, potential customers, suppliers, distributors, agents, sales representatives, employees, independent contractors, or other persons or entities with
which the Company or any of its Subsidiaries conducts business. For purposes of this Agreement, “Competing Product” means any musculoskeletal or any other product developed, manufactured, marketed, distributed, sold or intended to
be sold by the Company or any of its Subsidiaries and with which the Participant worked or was otherwise involved during the last two (2) years of Participant’s Employment. 

c. Non-Solicitation. Participant agrees that the Company would likely suffer significant and irreparable harm from
Participant’s solicitation of employees, distributors, distributors’ sales representatives, sales representatives, customers, suppliers or vendors of the Company or any of its Subsidiaries during the Participants’ Employment and for
some period of time thereafter. Accordingly, by accepting an award under the Plan, Participant agrees that he or she will not, during Participant’s Employment and for a period of twelve (12) months following termination of his or her
Employment, whether on his or her own behalf or on behalf of any other Person, either directly or indirectly (i) hire, solicit, induce, persuade, or entice, or endeavor to solicit, induce, persuade, or entice any person who is then employed by
or otherwise engaged to perform services for the Company or any of its Subsidiaries to leave that employment or cease performing those services, (ii) solicit, induce, persuade, or entice, or endeavor to solicit, induce, persuade, or entice any
Person who is a past or current customer, supplier, or vendor of the Company or any of its Subsidiaries to cease being a customer, supplier, or vendor of the Company or any of its Subsidiaries or to divert all or any part of such Person’s
business from the Company or any of its Subsidiaries or (iii) solicit, induce, persuade, or entice, or endeavor to solicit, induce, persuade, or entice any distributor, sales representative or associate of the Company or any of its Subsidiaries
to terminate their relationship or association with the Company or any of its Subsidiaries or distributors, or do any act which may result in the impairment of the relationship between the Company or any of

  
 7 

 
its Subsidiaries and their respective agents, employees, consultants, representatives or distributors. 
 d. Company’s Remedies for Violation of Non-Competition or Non-Solicitation Covenant. In the event that either the Participant’s Employment with the Company is terminated for Cause or the
Participant violates any of the restrictive covenants set forth in Section 10(a), Section 10(b) or Section 10(c): 
  

	 	i.	All Options held by such Participant, whether vested or unvested, shall be immediately canceled as of the commencement of business on the date on which the
Participant’s Employment is terminated for Cause or the first date on which such violation occurs; 

  

	 	ii.	In either case prior to the Agreement Termination Date, the Company (or its designated assignee) shall have (A) the call rights, with respect to shares of Common
Stock held by the Participant (including shares acquired through the exercise of Options under the Plan), that are set forth in Section 3(b)(ii)(A) of the Management Stockholders’ Agreement and (B) the right to receive from the
Participant the payments described in Section 3(b)(v) of the Management Stockholders’ Agreement (if any); and 

  

	 	iii.	In either case, following the Agreement Termination Date, the Participant shall be obligated to pay to the Company as liquidated damages, in addition to all other
rights and remedies the Company may have, an amount equal to the amount which the Participant will be required to recognize in income for U.S. federal income tax purposes as a result of such Participant’s exercise of Options at any time
following, or within one year prior to, the date of termination of his or her Employment. 

 e.
Remedies. Except as provided in Section 10(f), the Company’s sole recourse under the Plan against the Participant for any violation by the Participant of any of the restrictive covenants set forth in Section 10(b) or
Section 10(c) shall be the rights and remedies described in Section 10(d). The Company’s rights under Section 10(d) shall be in addition to, and shall not in any way prejudice the Company with respect to, any other rights and
remedies the Company may have in the event of any violation by the Participant of the restrictive covenants set forth in Section 10(a). 
 f. Payment for Compliance with Non-Competition and Non-Solicitation Covenants. 
  

	 	i.	 The Participant hereby agrees that if his or her Employment with the Company is terminated for any reason: (i) the Company shall have the right
(which it may exercise or not exercise in its sole discretion in accordance with Section 10(f)(ii) hereof) to 

  
 8 

	 	
(A) continue paying the Participant his or her base salary (as in effect on the date of termination of the Participant’s Employment), in accordance with the Company’s normal
payroll practices, for a period not to exceed twelve (12) months following the date of termination of the Participant’s Employment (the “Salary Continuation Period”) and (B) pay the Participant an amount equal to the
product of (x) the lesser of the annual bonus the Participant received for the year immediately preceding the year in which the Participant’s employment is terminated (if any) or the Participant’s target annual bonus for the year in
which the Participant’s employment is terminated (if any) and (y) a fraction, the numerator of which is the number of whole calendar months in the Salary Continuation Period and the denominator of which is twelve (12), which amount shall
be paid in installments over the course of the Salary Continuation Period in accordance with the Company’s normal payroll practices (such salary and bonus payments, the Participant’s “Non-Compete Compensation”) and
(ii) during the Salary Continuation Period (if any), the Participant shall be bound by, and shall comply with the provisions of, Section 10(b) and Section 10(c) hereof. The Company’s rights under this Section 10(f) shall be
in addition to, and shall not in any way prejudice the Company with respect to, its rights under Section 10(d) hereof. For the avoidance of doubt, the Participant shall remain bound by the provisions of Section 10(a) hereof regardless of
whether or not the Company exercises its rights under this Section 10(f). 

  

	 	ii.	In the event that a Participant’s Employment is terminated by the Participant or the Company as described in Section 10(f)(i) hereof, the Company
automatically shall be deemed to exercise its rights under this Section 10(f) and the Salary Continuation Period for such Participant shall be deemed to be twelve (12) months following the date of termination of the Participant’s
Employment, unless the Company notifies the Participant, within thirty (30) business days following the effective date of termination of the Participant’s Employment, either that it will not exercise its rights under this
Section 10(f) or that the length of the Salary Continuation Period for such Participant shall be less than twelve (12) months. 

  

	 	iii.	 The Company in its sole discretion may elect, at any time during the Salary Continuation Period, to discontinue the Salary Continuation Period by
notifying the Participant in writing at least thirty (30) business days prior to the date on which the Salary Continuation Period will terminate. If the Company elects to discontinue the Salary Continuation Period as described in the preceding
sentence, then the Participant shall cease to be bound by 

  
 9 

	 	
the provisions of Section 10(b) and Section 10(c) hereof as of the date on which the Salary Continuation Period terminates. 

 

	 	iv.	Notwithstanding anything in the Plan or this Agreement to the contrary, in the event that the Participant violates any provision of Section 10(b) or
Section 10(c) during the Salary Continuation Period, (A) the Company shall immediately cease paying the Participant the Non-Compete Compensation and (B) the Participant shall nonetheless remain bound by the provisions of
Section 10(b) and Section 10(c) hereof for the remainder of the period during which he or she would have been bound by such obligations if no such violation had occurred. 

g. The restrictive covenants set forth in Sections 10(a), 10(b) and 10(c) hereof shall be in addition to, and nothing in
this Section 10 (including, without limitation, the Company’s rights under Section 10(f) hereof and any election by the Company to exercise or not exercise such rights) shall in any way prejudice the Company’s rights with respect
to, any restrictive covenants and confidentiality obligations (or similar restrictions and obligations) in favor of the Company which are applicable to the Participant by law, in equity, or under any other plan, program, agreement or arrangement
with the Company (including, without limitation, the Participant’s common law obligations with respect to the Company’s confidential information). 
 h. The Participant recognizes that a breach or threatened breach of the restrictive covenants set forth in Sections 10(a), 10(b) and 10(c) hereof may give rise to irreparable injury to the Company,
inadequately compensable in damages. Accordingly, the Participant agrees that in the event of a breach or threatened breach of the restrictive covenants set forth in Section 10(a) hereof or, during the Salary Continuation Period (if any),
Section 10(b) or Section 10(c) hereof, the Company may seek and obtain injunctive relief, temporary, preliminary or permanent, against such breach or threatened breach, in addition to recovering any monetary damages from the Participant.
The Participant further agrees and acknowledges that greater injury would likely result by refusing the Company or its successors or assigns injunctive relief than by granting such injunctive relief. The Participant hereby waives any right to
require the Company to obtain a bond in connection with any such injunctive proceedings. The Company shall also be entitled to recover from the Participant its reasonable attorneys’ fees and costs of any action that it successfully brings
against the Participant for any breach or threatened breach described in this Section 10(h). 
 i. The
restrictive covenants set forth in this Section 10 shall be binding upon, and shall inure to the benefit of, the Company, its Affiliates and their respective successors and assigns. By accepting an award under the Plan, the Participant agrees
that the Company shall have the right to assign any or all of its rights hereunder to any successor in interest, whether by merger, consolidation, sale of assets, public offering, or otherwise. 

  
 10 

 j. Notwithstanding anything to the contrary in the Plan or this Agreement,
the construction, enforceability and interpretation of this Section 10 shall be governed by the laws of the state in which the Participant’s employer operates its principal place of business. Except as expressly provided herein, the
failure of the Company to insist upon performance of any of the provisions of this Section 10 or to pursue its rights hereunder shall not be construed as a waiver of any such provisions or the relinquishment of any such rights. The Participant
further agrees that any legal action relating to this Section 10 shall be commenced and maintained exclusively before any appropriate venue located in the local, county or federal court in which the Participant’s employer operates its
principal place of business. Participants hereby submit to the jurisdiction of such courts and waive any right to challenge or otherwise object to personal jurisdiction or venue, in any action commenced or maintained in such courts. 

11. Transfer and Lock-Up of Shares. If the Company files a registration statement registering shares held by the Majority
Stockholder in an Initial Public Offering or any secondary registered equity offering, then, in addition to the terms and conditions set forth in the Management Stockholders’ Agreement, the Participant or his or her Permitted Transferee shall
not, following expiration of the Lock-Up Period (as defined in the Management Stockholders’ Agreement), sell more than one-third (1/3) of the shares of such Participant’s or Permitted Transferee’s Common Stock acquired pursuant
to the exercise of the Option during the twelve (12) months following such expiration or more than two-thirds (2/3) of the shares of such Participant’s or Permitted Transferee’s Common Stock acquired pursuant to the exercise of
the Option during the twenty-four (24) months following such expiration; provided that if the Lock-Up Period expires less than three (3) years prior to the tenth anniversary of the original Grant Date (such period of time, the
“Remaining Period”), such Participant or Permitted Transferee may sell up to one-third (1/3) of the shares of such Participant’s or Permitted Transferee’s Common Stock acquired pursuant to the exercise of the Option
during the first third of the Remaining Period, up to two-thirds (2/3) of such shares during the second third of the Remaining Period and all of such shares during the remaining third of the Remaining Period. 

12. Adjustment. Notwithstanding anything to the contrary set forth in the Plan or this Agreement, in the event that the
Company’s Biomet 3i dental business (“3i”) separates from Biomet, Inc. in a tax-free spin-off (the “Spin”) prior to December 31, 2013, the Board shall make such adjustments as it in good faith considers
appropriate to effectuate the Company’s business purposes in causing the Spin to occur and that are equitable to Participants, including without limitation adjustment to the number, type or issuer of shares of stock subject to some or all of
the Options outstanding on the date the Spin occurs; substitution of cash or other property for the Common Stock subject to such Options; or change in any performance-based vesting or other conditions applicable to such Options. For the avoidance of
doubt, in making any such adjustments the Board need not adjust Options held by different Participants nor Options held by a single Participant in a uniform manner. 
 13. Integration. This Agreement, and the other documents referred to herein or delivered pursuant hereto which form a part hereof contain the entire understanding of the parties with respect to its
subject matter. There are no restrictions, agreements, promises, representations, warranties, covenants or undertakings with respect to the subject matter hereof other than those expressly set forth herein and in the Plan. The Participant
hereby 

  
 11 

 
acknowledges that this Agreement, the Plan and the Management Stockholders’ Agreement supersede all prior agreements and understandings between the parties with respect to the subject
matter of this Agreement, including without limitation, any provision in such prior agreement or understanding, including without limitation any change of control agreement, that provides for the acceleration or waiver of any time periods,
conditions or contingencies relating to the exercise or realization of, or lapse of restrictions under, any outstanding equity award held by the Participant. 
 14. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which shall constitute one and the same instrument. 

15. Governing Law. Except as expressly provided in Section 10(j) hereof, this Agreement shall be governed by and construed
and enforced in accordance with the laws of the State of Delaware without regard to the provisions governing conflict of laws. 

16. Participant Acknowledgment. The Participant hereby acknowledges receipt of a copy of the Plan. The Participant hereby
acknowledges that all decisions, determinations and interpretations of the Board in respect of the Plan, this Agreement and the Option shall be final and conclusive. The Participant further acknowledges that, prior to the Agreement Termination Date,
no exercise of the Option or any portion thereof shall be effective unless and until the Participant has executed the Management Stockholders’ Agreement and the Participant hereby agrees to be bound thereby. Notwithstanding the foregoing, any
determination made by the Board relating to the characterization of the Participant’s termination of Employment shall be subject to a de novo standard of review. 
 17. Modifications. To the extent that the Company modifies the expiration date, or offers to all or substantially all active employees of the Company and its Affiliates the opportunity to modify
the expiration date, of all or substantially all Options granted under the Plan to employees on substantially the same terms and conditions as apply to the Option granted to Participant pursuant to this Agreement (“Similar Options”)
at any time, whether through amendment of the Plan and/or Stock Option Grant Agreements, an exchange offer or otherwise, the expiration date of the Option granted to Participant pursuant to this Agreement shall likewise be modified at such time or
shall be eligible for modification without regard to any other additions or modifications to the terms and conditions applicable to such Similar Options; provided further that no modification will be made if it would violate any applicable laws or
result in tax becoming due under Section 409A of the Code. 
 [Signature page follows] 

  
 12 

 IN WITNESS WHEREOF, the Company has caused this Agreement to be duly executed by its duly
authorized officer and said Participant has hereunto signed this Agreement on his own behalf, thereby representing that he has carefully read and understands, and agrees to be bound by, this Agreement, the Plan and the Management Stockholders’
Agreement as of the day and year first written above. 
  

									
	LVB Acquisition, Inc.	 		 	Participant
			
	 /s/ Bradley J. Tandy
	 		 	 /s/ Jeffrey R. Binder

	By:	 	Bradley J. Tandy	 		 	By:	 	Jeffrey R. Binder
	Title:	 	Senior Vice President,	 		 		 	
		 	General Counsel and Secretary	 		 	Date:	 	January 14, 2013

  
 13Amendment No. 1 Rights Agreement

 EXHIBIT 4.1 
 AMENDMENT NO. 1 TO RIGHTS AGREEMENT 
 This Amendment No. 1 to Rights
Agreement (this “Amendment”) is dated as of January 14, 2013 and effective as of January 8, 2013 (the “Effective Date”) and amends the Rights Agreement, dated as of July 19, 2011 and effective as of July 18,
20011, between Breeze-Eastern Corporation, a Delaware corporation (the “Company”), and Computershare Trust Company, N.A. as Rights Agent (the “Rights Agent”). Capitalized terms used herein and not otherwise defined shall
have the meanings ascribed to such terms in the Rights Agreement. 
 WHEREAS, on January 8, 2013, the Board determined it
is in the best interests of the Company and its shareholders to amend the Rights Agreement on the terms set forth herein; 

WHEREAS, Section 27 of the Rights Agreement provides that, at any time before any Person becomes an Acquiring Person, the Company,
by action of the Board, may amend the Rights Agreement without the approval of any holders of Rights; 
 WHEREAS, as of the date
of this Amendment, no Person has become an Acquiring Person; 
 WHEREAS, the Board has determined that it is in the best
interest of the Company to amend the Rights Agreement to increase the threshold by which a Person becomes an Acquiring Person from 10% to 12.5%; 
 WHEREAS, the Company has directed the Rights Agent to amend the Rights Agreement as set forth herein, pursuant to Section 27 of the Rights Agreement. 

NOW THEREFORE, in consideration of the foregoing and other good and valuable consideration, the receipt and sufficiency of which the
parties hereby acknowledge, the Company and the Rights Agent hereby amend the Rights Agreement as follows: 
  

	 	1.	Section 1(a) of the Rights Agreement is hereby amended in its entirety as follows: 

(a) “Acquiring Person” shall mean any Person who or which, together with all Affiliates and Associates of such Person,
shall be the Beneficial Owner of 12.5% or more of the shares of Common Stock of the Company then outstanding, but shall not include (i) the Company, (ii) any Subsidiary of the Company, (iii) any employee benefit plan of the Company or
any Subsidiary of the Company, or any Person holding shares of Common Stock for or pursuant to the terms of any such plan to the extent, and only to the extent, of such shares of Common Stock so held, or (iv) an Exempted Person. Notwithstanding
anything in this definition of “Acquiring Person” to the contrary: 
 (i) no Person shall become an
“Acquiring Person” as the result of an acquisition of shares of Common Stock by the Company which, by reducing the number of shares of Common Stock outstanding, increases the percentage of the shares of Common Stock beneficially owned by
such Person, together with all Affiliates and Associates of such Person, to 12.5% or more of the shares of Common Stock of the Company then 

 
outstanding; provided, however, that if a Person, together with all Affiliates and Associates of such Person, shall become the Beneficial Owner of 12.5% or more of the
shares of Common Stock of the Company then outstanding by reason of share acquisitions by the Company and shall, after such share acquisitions by the Company, become the Beneficial Owner of any additional shares of Common Stock of the Company (other
than pursuant to a dividend or distribution paid or made by the Company on the outstanding Common Stock or pursuant to a split or subdivision of the outstanding Common Stock), then such Person shall be deemed to be an “Acquiring Person”
unless, upon becoming the Beneficial Owner of such additional shares of Common Stock, such Person, together with all Affiliates and Associates of such Person, does not beneficially own 12.5% or more of the Common Stock then outstanding; 

(ii) if the Board determines that a Person who would otherwise be an “Acquiring Person,” as defined pursuant to
the foregoing provisions of this paragraph (a), has become such inadvertently (including, without limitation, because (A) such Person was unaware that it beneficially owned a percentage of the then outstanding Common Stock that would otherwise
cause such Person to be an “Acquiring Person” or (B) such Person was aware of the extent of its Beneficial Ownership of Common Stock but had no actual knowledge of the consequences of such Beneficial Ownership under this Agreement),
and such Person divests as promptly as practicable a sufficient number of shares of Common Stock so that such Person would no longer be an “Acquiring Person,” as defined pursuant to the foregoing provisions of this paragraph (a), then such
Person shall not be deemed to be or to have become an “Acquiring Person” for any purposes of this Agreement as a result of such inadvertent acquisition unless and until such Person shall again become an “Acquiring Person”;

 (iii) if, as of the date hereof or prior to the first public announcement of the adoption of this Agreement,
any Person is or becomes the Beneficial Owner of 12.5% or more of the shares of Common Stock outstanding, such Person shall not be deemed to be or to become an “Acquiring Person” unless and until such time as such Person shall, after the
first public announcement of the adoption of this Agreement, become the Beneficial Owner of additional shares of Common Stock (other than pursuant to a dividend or distribution paid or made by the Company on the outstanding Common Stock or pursuant
to a split or subdivision of the outstanding Common Stock), unless upon becoming the Beneficial Owner of such additional shares of Common Stock, such Person is not then the Beneficial Owner of 12.5% or more of the shares of Common Stock then
outstanding; and 
 (iv) no Person shall become an “Acquiring Person” solely as a result of any
unilateral grant of any security by the Company, or through the exercise of any options, warrants, rights or similar interests (including restricted stock) granted by the Company to its directors, officers and
employees; provided, however, that if a Person, who or which together with all Affiliates and Associates, shall become the Beneficial Owner of 12.5% or more of the shares of Common Stock of the Company then outstanding by
reason of a unilateral grant of a security by the Company, or through the exercise of any options, warrants, rights or similar interests (including restricted stock) granted by the 

 
Company to its directors, officers and employees, such Person shall nevertheless be deemed to be an “Acquiring Person” if, subject to Section 1(a)(ii), such Person, together with
all Affiliates and Associates, thereafter becomes the Beneficial Owner of any additional shares of Common Stock (unless upon becoming the Beneficial Owner of additional shares of Common Stock, such Person, together with all Affiliates and
Associates, does not beneficially own 12.5% or more of the Common Stock then outstanding), except as a result of (y) a dividend or distribution paid or made by the Company on the outstanding Common Stock or a split or subdivision of the
outstanding Common Stock; or (z) the unilateral grant of a security by the Company, or through the exercise of any options, warrants, rights or similar interest (including restricted stock) granted by the Company to its directors, officers and
employees. 
 2. No Other Amendments; Effect of Amendment. Except as and to the extent expressly modified by this
Amendment, the Rights Agreement and the exhibits thereto shall remain in full force and effect in all respects without any modification (it being understood that upon the expiration of the Rights in accordance with the terms of the Rights Agreement,
as amended hereby, the Rights Agreement shall be terminated and of no further force or effect whatsoever without any further action on the part of the Company or the Rights Agent). This Amendment shall be deemed an amendment to the Rights Agreement
and shall become effective on the Effective Date. In the event of a conflict or inconsistency between this Amendment and the Rights Agreement and the exhibits thereto, the provisions of this Amendment shall govern. 

3. Counterparts. This Amendment may be executed in any number of counterparts and each of such counterparts shall for all purposes
be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument. A signature to this Agreement transmitted electronically shall have the same authority, effect, and enforceability as an original
signature. 
 4. Severability. If any term, provision, covenant or restriction of this Amendment is held by a court of
competent jurisdiction or other authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions of this Amendment shall remain in full force and effect and shall in no way be affected, impaired or
invalidated. 
 5. Descriptive Headings. Descriptive headings in this Amendment are inserted for convenience only and
shall not control or affect the meaning or construction of any of the provisions hereof. 
 6. Further Assurances. Each
of the parties to this Amendment shall cooperate and take such action as may be reasonably requested by the other party in order to carry out the provisions and purposes of this Amendment, the Rights Agreement and the transactions contemplated
hereunder and thereunder. 
 7. Governing Law. This Amendment shall be deemed a contract made under the laws of the State
of Delaware and for all purposes shall be governed by and construed in accordance with the laws of such State applicable to contracts to be made and performed entirely within such State. 

 [Signature page to Follow on Next Page] 

 IN WITNESS WHEREOF, the parties have caused this Amendment to be duly executed, all as of
the Effective Date. 
  

							
	BREEZE-EASTERN CORPORATION
		
	By:	 	/s/ Mark D. Mishler
		 	Name:	 	Mark D. Mishler
		 	Title:	 	Chief Financial Officer
	
	 COMPUTERSHARE TRUST COMPANY, N.A.
 as Rights Agent

		
	By:	 	/s/ Dennis Moccia
		 	Name:	 	Dennis Moccia
		 	Title:	 	Manager, Contract Administration

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00211-of-00352.parquet"}]]